Study 18 of 41Erythropoietin (EPO) literatureNatureTop journal2026
Erythropoietin receptor on cDC1s dictates immune tolerance.
Not reported in abstract.
Where it sits
this study against the rest of the erythropoietin (epo) corpus6
Preclinical · this one
26
Observational
1
Open-label
2
Randomised
6
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Erythropoietin (EPO) corpus
DErythropoietin beyond red blood cells: Systemic and oncological functions (Review).Molecular medicine reports · 2026reviewDSodium-Glucose Cotransporter 2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and Erythropoiesis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.JAMA · 2026 · Hemoglobin changed by 0.55 g/dL in the SGLT2 inhibitor group, P<0.001.reviewBResponsiveness to Erythropoiesis‑Stimulating Agents and Hemoglobin Variability in Japanese Patients With End‑Stage Kidney Diseasebiorxiv-preprint · 2026 · ERI was positively correlated with Hb-RSD (r = 0.473, p = 0.003).HumanBBlood Free Carnitine Level is an Independent Determinant of Erythrocyte Membrane Homogeneity and Osmotic Resistance in Maintenance Hemodialysis Patientsbiorxiv-preprint · 2026 · Higher FC levels were associated with increased OFT slope a (β=0.6090, P=0.036).HumanBGenetic mimicry of haematopoietic growth factor signalling: efficacy–safety trade-offs for cytopenias by drug-target Mendelian randomisationbiorxiv-preprint · 2026 · OR 0.65, 95% CI 0.49–0.86, P=0.0026 for lower thrombocytopenia risk with higher MPL expression.HumanCIn vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cellsbiorxiv-preprint · 2026 · >70% HbF-positive erythroid cells in treated miceAnimal